Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vasopressin and Inhaled Prostacyclin in Pediatric Pulmonary Hypertension

This study has been terminated.
(Difficulty with patient recruitment)
Sponsor:
Information provided by (Responsible Party):
Lindsay Ryerson, University of Alberta
ClinicalTrials.gov Identifier:
NCT01370096
First received: June 8, 2011
Last updated: October 24, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2016
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)